FDA Warns IBS Drug Viberzi May Cause Pancreatitis In Patients Without Gallbladder
SILVER SPRING, Md. — The Food and Drug Administration on March 15 issued a drug safety communication warning that the irritable bowel syndrome (IBS) drug Viberzi has been associated with reports...To view the full article, register now.
Already a subscriber? Click here to view full article